Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis
- 4 February 2010
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 21 (3) , 185-192
Abstract
We evaluated in this study the efficacy and safety of an alternate regimen using clobetasol propionate 0.05% shampoo (CP shampoo) for long-term control of scalp psoriasis. Patients with moderate scalp psoriasis (Global Severity Score [GSS] of 3 on a 0–5 scale) first received CP shampoo once daily for 4 weeks. Patients with a GSS ≤ 2 were then randomized into the maintenance phase, receiving CP shampoo or vehicle twice weekly. When relapse (GSS > 2) occurred, patients received the 4-week daily CP shampoo treatment. Patients who had a GSS ≤ 2 afterwards reinitiated the twice-weekly maintenance according to the original randomization scheme. Among the 168 patients enrolled, 141 (83.9%) had a GSS ≤ 2 after the initial phase. The median time to first relapse was 141 days with CP shampoo, almost 4 months later than with vehicle (30.5 days;p < 0.0001). After 6 months, the percentage of patients who had no relapse was significantly higher with CP shampoo (40.3%) than with vehicle (11.6%;p < 0.001). CP shampoo was also safe during the 7-month study period, without leading to more cases of skin atrophy, telangiectasia, hypothalamic-pituitary-adrenal (HPA) axis suppression or adverse events compared to vehicle. The alternate treatment regimen with CP shampoo is efficacious and safe for long-term management of moderate scalp psoriasis.Keywords
This publication has 24 references indexed in Scilit:
- Scalp psoriasis: a review of current topical treatment optionsJournal of the European Academy of Dermatology and Venereology, 2007
- Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasisJournal of the American Academy of Dermatology, 2006
- A clinician's paradigm in the treatment of psoriasisJournal of the American Academy of Dermatology, 2005
- Therapeutic options in the treatment of psoriasis and atopic dermatitisJournal of the American Academy of Dermatology, 2005
- Quality of life issues in psoriasisJournal of the American Academy of Dermatology, 2003
- Psoriasis of the ScalpAmerican Journal of Clinical Dermatology, 2001
- Two considerations for patients with psoriasis and their clinicians:Journal of the American Academy of Dermatology, 2000
- Patient Compliance and Disease Management in the Treatment of Psoriasis in the NetherlandsDermatology, 2000
- Clearance is not a realistic expectation of psoriasis treatmentJournal of the American Academy of Dermatology, 2000
- Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerationsJournal of the American Academy of Dermatology, 1998